Featured News
570Wire StoriesInnoCare Announces First Subject Dosed in Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the...
- 540Wire Stories
Center Coast Brookfield MLP & Energy Infrastructure Fund Considering Strategic Options
NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) — Brookfield Public Securities Group (“PSG”), the investment adviser to Center Coast Brookfield MLP &...
- 628Wire Stories
V-SQUARE announces launch of V-Square MSCI Global Equity ESG Materiality and Carbon Transition Indexed Strategy for Australian Asset Owners
CHICAGO–(BUSINESS WIRE)–#Australia–Chicago based V-Square Quantitative Management LLC (V-Square), a global asset management firm with sustainability at its core, announced today that it...
- 558Wire Stories
Sinclair Announces Agreements with Korean Broadcasters to Further NextGen Broadcasting
HUNT VALLEY, Md.–(BUSINESS WIRE)–Sinclair Broadcast Group, Inc. (Nasdaq: SBGI), today announced that the company has entered into agreements with two top Korean...
- 638Wire Stories
CF Industries Holdings, Inc. Reports First Half 2022 Net Earnings of $2.05 Billion, Adjusted EBITDA of $3.60 Billion
Strong Operational Performance and Wide Energy Spreads Drive Record Results DEERFIELD, Ill.–(BUSINESS WIRE)–CF Industries Holdings, Inc. (NYSE: CF), a leading global manufacturer...
- 491Wire Stories
Navidea Biopharmaceuticals Announces Publication of Study Examining Use of Tc99m Tilmanocept for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Melanoma and Oral Cancer in Australia
DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents...
- 511Wire Stories
Fabrinet to Announce Fourth Quarter and Fiscal-Year 2022 Financial Results on August 15, 2022
BANGKOK–(BUSINESS WIRE)–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment...
- 513Wire Stories
GC Biopharma Reports Q2 2022 Results
YONGIN, South Korea–(BUSINESS WIRE)–GC Biopharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated...
- 572News
SOLARR Announces SLRR Token Listing on BitMart, Launches Free Minting for Creators
HONG KONG SAR – Media OutReach – 1 Aug 2022 – SOLARR, a revolutionary decentralized ecosystem for liquifying NFTs, announced its listing...
- 579Wire Stories
Convocation of the General Extraordinary Shareholders Meeting of INVL Baltic Real Estate and draft resolutions on agenda issue
Special closed-ended type real estate investment company INVL Baltic Real Estate, legal entity code 152105644, the registered address Gyneju str. 14 Vilnius,...
- 636Wire Stories
Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
Company expands financing with additional $33 million Dosing complete in Phase 1 SAD study of GSBR-1290, an oral GLP-1R agonist in development...
